AVAILABLE ON-DEMAND

CME/CE

Jointly provided by Postgraduate Institute for Medicine and HealthHIV

This activity is supported in part by an independent educational grant from Merck



Target Audience

This activity is intended for physicians, physician assistants, pharmacists, nurse practitioners, registered nurses, social workers, health education specialists, and other allied healthcare professionals engaged in the care of patients with HIV.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Implement strategies related to the national initiatives to end the epidemics.
  • Describe the effect of utilization management strategies on access to PrEP treatments, uptake, and utilization.
  • Demonstrate ability to create new partnerships and implement a synchronized approach across multiple disciplines when addressing patient/client care.
  • Identify current national, state and local efforts to increase patient access to care.
  • Apply the integration of HIV, HCV, STI and other communicable diseases’ prevention and care services into primary healthcare.
  • Identify information, resources and tools to sustain and evolve in a dynamic environment and adequately address the needs of the providers, patients, and those in need.
  • Discuss methods for tracking, monitoring, and spending program income.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 13.5 contact hour(s) (1.35 CEUs) of the Accreditation Council for Pharmacy Education. 

Type of Activity: Knowledge 

AIDS Therapy Sessions UAN: JA4008162-9999-21-2897-L02-P

General Pharmacy Sessions UAN: JA4008162-9999-21-2994-L04-P

Disease State Management/Drug Therapy Sessions UAN: JA4008162-9999-21-2896-L01-P

Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.  An ACPE credit worksheet will be provided when completing the evaluation to determine credit amounts to claim for each UAN. 

Continuing Physician Assistant Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 13.5 contact hours. 

An ANCC credit worksheet will be provided when completing the evaluation to determine credit amounts to claim.

Continuing Social Worker Education

As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.  Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 13.5 clinical competency* continuing education credits.

*A Worksheet will be provided upon completion of the evaluation to document the amount of clinical competency credit issued. 

Continuing Health Education Specialists Education

An application has been submitted to NCHEC for CHES/MCHES credits.

Faculty

Include link to faculty list (include titles and affiliations)

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty [this section is now complete/final]

The following faculty/planning committee members reported the financial relationships or relationships with ineligible entities related to the educational content of this continuing education activity:

Name of FacultyConflicts of Interest
Jonathan ApplebaumConsulting Fees: Viiv Healthcare; Merck
Guillermo ChaconConsulting Fees:Merck HIV Advisory Board
Larry CoreyConsulting Fees: Vir BiotechnologyOwnership Interest less than 5%: Vir Biotechnology
Dazon Dixon DialloConsulting Fees: Gilead, Merck, ViiV Healthcare, GSK
DeMarc Hickson Advisory Board: Viiv Healthcare, Merck; GileadContracted Research: Gilead
Kathie HiersConsulting Fees: Merck
Terry Kemp-KnickContracted Research: Gilead Sciences
Jen LawsConsulting Fees: Community Access National Network, Prevention Access Campaign, Westat (CDC Let’s Stop HIV Together campaign manager)
Cordella LyonConsulting Fees: Gilead SciencesOther: Focus Testing Partner – Gilead Sciences
Fernando Mena CarrascoAdvisory Board: Gilead Sciences (single event)
Leandro MenaConsulting Fees: Gilead Sciences Viiv Healthcare, Roche, MerckContracted Research: Gilead, GSK, ViiV Healthcare, Merck, Janssen, Binx Health (Atlas Genetics), Becton Dickinson, Rheonix, Click Diagnostics, Roche, Evoem, Westat, Merck, Lupin
Lesley MillerConsulting Fees: AbbVieContracted Research: Gilead
Carl SchmidConsulting Fees: Gilead Sciences
Donna SweetConsulting Fees: Merck, JanssenContracted Research: GlaxoSmithKline; Cytodyn
Dafina WardContracted Research: Gilead, ViiV Healthcare, Janssen

All remaining faculty/planning committee members have nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The HealthHIV planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Request for Credit

Request for CME/CE Credits

Please Use the Separate Instructions Below for CHES/MCHES Credits

In order to obtain your CME/CE certificate, please follow the steps below at the conclusion of the virtual conference:

  1. Go to www.cmeuniversity.com
  2. Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    1. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  3. Type in 16656 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  4. Click on the activity title when it appears
  5. Choose the type of credit you desire
  6. Complete the online Evaluation
  7. Receive an immediate CME/CE Certificate to download and/or print for your files

Request for CHES/MCHES Credits

In order to obtain your CHES/MCHES certificate, please follow the steps below at the conclusion of the activity:

  1. Go to www.cmeuniversity.com
  2. Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  3. Type in 16819 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  4. Click on the activity title when it appears
  5. Choose the type of credit you desire
  6. Complete attestation
  7. Use the worksheet link to calculate your actual credit
  8. Receive an immediate CME/CE Certificate to download and/or print for your files

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check your NABP account within thirty (30) days to make sure the credit has posted. 

Questions?

If you have questions regarding the certification of this activity, please contact PIM via email at [email protected].

ViiV Healthcare: Our Goal — End the Epidemic
Mesmerize
Since 2013, Rare Patient Voice has awarded patients and caregivers over $7,000,000!
HealthMerch
ViiV-Healthcare_SYNChronicity-Website-leaderboard-ad_2021
Janssen
Avita_Sync21_HealthHIV_Banner
Mesmerize
Rare-Patient-Leaderboard
HealthMerch
previous arrow
next arrow